ATL boosts power Doppler performance
ATL has released a new versionof its power mode color Doppler technology for imaging blood flowin small vessels. ATL increased the performance of the technologyand renamed it Color Power Angio Imaging, the Bothell, WA, companysaid last month. Color
ATL has released a new versionof its power mode color Doppler technology for imaging blood flowin small vessels. ATL increased the performance of the technologyand renamed it Color Power Angio Imaging, the Bothell, WA, companysaid last month.
Color Power Angio Imaging supersedes Doppler Power Imagingas the marketing term for the company's power mode Doppler technology.The technique displays the amplitude of blood flow rather thanthe velocity, giving physicians a better look at weak blood flowin small vessels.
Most major ultrasound vendors have adopted different versionsof Doppler blood-vessel roadmapping and the technology has beenwell received by clinicians. Few clinical papers on the technologyhave been published, due to its novelty, however. That could changewith this year's Radiological Society of North America meeting,according to ATL president David Perozek.
"At the RSNA conference there will be a number of clinicalpapers presented, indicating and evaluating the clinical utilityof the Color Power Angio mode," Perozek said.
Also last month, ATL released a new intraoperative scanheadfor vascular surgery applications. The Entos CL10-5 transducercan help vascular surgeons identify anatomic defects that mayresult from surgery, enabling them to take corrective action whilestill in the operating room, according to the company.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
